TW386084B - A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine - Google Patents

A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine Download PDF

Info

Publication number
TW386084B
TW386084B TW83102060A TW83102060A TW386084B TW 386084 B TW386084 B TW 386084B TW 83102060 A TW83102060 A TW 83102060A TW 83102060 A TW83102060 A TW 83102060A TW 386084 B TW386084 B TW 386084B
Authority
TW
Taiwan
Prior art keywords
guanine
reaction
formula
temperature
ministry
Prior art date
Application number
TW83102060A
Other languages
Chinese (zh)
Inventor
Stefano Turchetta
Sabina Pucci
Gianfranco Piccoli
Giovanni Frare
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Priority to TW83102060A priority Critical patent/TW386084B/en
Application granted granted Critical
Publication of TW386084B publication Critical patent/TW386084B/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

毒劑)之製備被述於,例如,比利時專利833,006號中,該 法自鳥嘌呤開始,先在2-胺基* 6-及9-位三個位置上行三 甲矽烷化。然後將生成之矽烷化中間物用2-苄醸氧乙氧甲 基氯處理,K形成(N2及He位置除保護基後)9-(2-ΐ釀 氧基)-乙氧甲基鳥嘌呤,藉在甲醇中氨解而自其中回收阿 塞克樓佛。該法使用過量甚多的烷化劑,因而明顯有成本 及浪費的問題,再者,其導致生成頗不純之產物,7 -取代 異構物之存在量就藥用観點而言之無法接受。 英國專利1,567,δ71揭示另一種方法,其中2-位胺基之 保護藉醯化進行;該專利揭示Μ乙醯基、丙釀基、丁醯基 及苄醯基做為醯化基,惟其中唯一述及之例子為Ν 2 , 9 -二 乙醯基鳥嘌呤與2 -氧雜-1 , 4 -二乙醯氧丁烷反應,得到Ν 2 -乙醢基-9 - (2 -乙醯氧基)乙氧甲基鳥嘌呤,然後將其水解得 到最後之阿塞克羅佛,該反應之產率若僅就未形成顯著量 (達13 % )之7 -異搆物而言令人滿意,不過其需要昂貴的純 本紙張尺度適用中國國家標準(CNS ) Α4規格(210乂297公釐) 訂 經濟部中央標準局員工消费合作社印製 -3-修正頁The preparation of poison) is described, for example, in Belgian Patent No. 833,006. This method starts with guanine, and first trimethylsilylates at the 3-amino * 6- and 9-positions. The resulting silylated intermediate is then treated with 2-benzylacetoxyethoxymethyl chloride, and K is formed (after the protective group is removed at the N2 and He positions) Ascetic Loufo was recovered from it by ammonia hydrolysis in methanol. This method uses a large excess of alkylating agent, so there are obvious problems of cost and waste. Furthermore, it leads to the formation of quite impure products, and the amount of 7-substituted isomers is unacceptable in terms of pharmaceutical pupae. . British patent 1,567, δ71 discloses another method, in which the protection of the amine group at the 2-position is carried out by hydration; the patent discloses that Methyl, propyl, butyl, and benzyl are used as fluorenyl groups, among which The only example mentioned is the reaction of Ν 2, 9 -diethylfluorenylguanine with 2 -oxa-1, 4 -diethylfluorenyloxybutane to give Ν 2 -ethylfluorenyl-9-(2 -acetamidine (Oxy) ethoxymethylguanine, which is then hydrolyzed to give the final acecrofo, the yield of this reaction is only if the 7-isomer is not formed in significant amounts (up to 13%) Satisfied, but it requires expensive pure paper. Standards are applicable to China National Standards (CNS) Α4 (210 乂 297 mm). Ordered by the Consumer Standards Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs.

毒劑)之製備被述於,例如,比利時專利833,006號中,該 法自鳥嘌呤開始,先在2-胺基* 6-及9-位三個位置上行三 甲矽烷化。然後將生成之矽烷化中間物用2-苄醸氧乙氧甲 基氯處理,K形成(N2及He位置除保護基後)9-(2-ΐ釀 氧基)-乙氧甲基鳥嘌呤,藉在甲醇中氨解而自其中回收阿 塞克樓佛。該法使用過量甚多的烷化劑,因而明顯有成本 及浪費的問題,再者,其導致生成頗不純之產物,7 -取代 異構物之存在量就藥用観點而言之無法接受。 英國專利1,567,δ71揭示另一種方法,其中2-位胺基之 保護藉醯化進行;該專利揭示Μ乙醯基、丙釀基、丁醯基 及苄醯基做為醯化基,惟其中唯一述及之例子為Ν 2 , 9 -二 乙醯基鳥嘌呤與2 -氧雜-1 , 4 -二乙醯氧丁烷反應,得到Ν 2 -乙醢基-9 - (2 -乙醯氧基)乙氧甲基鳥嘌呤,然後將其水解得 到最後之阿塞克羅佛,該反應之產率若僅就未形成顯著量 (達13 % )之7 -異搆物而言令人滿意,不過其需要昂貴的純 本紙張尺度適用中國國家標準(CNS ) Α4規格(210乂297公釐) 訂 經濟部中央標準局員工消费合作社印製 -3-修正頁 A7 B7 修正補充 本年丨丨月1>曰 經濟部中央標準局員工消費合作社印製 玉、發明説明(7 拌下加人107 .4克(0· 502奠耳)NaI〇4並藉水浴之助將溫度 保持3 0 υ,連纊監測p Η值,使其大致在1 . 8 - 2 . 2之範圍内 。反應為一種溫和、恆定的放熱反應,於加入氧化劑後約 2小時完成。完成後,將反應混合物冷卻至5 13,然後過濾 ,用水洗滌及乾燥。得到S 2克甲醯基鳥嘌呤(3 )(產率:9 6 %),1^1^分析顯示纯度>98%。 4 c)H2 -甲醯基-9-(乙醯氧基)乙氧甲基鳥嘌呤(4,R=CH3) 將100克(0.55 9莫耳)甲醯基鳥嘌呤(3),300克(1.705莫 ΐ)2-氧雜-1,4-二乙醯氧基-丁烷及2克(0.0105莫耳)對-甲苯磺酸置於油浴上,裝有溫度計及蒸餾裝置之5 0 0毫升 圓底燒瓶中。將該系統減壓( 30-40fflflllU)並將物質在約1小 時内加熱至内部溫度為1 1 S — 1 2 2 °C。將溫度保持在U S -1 2 2 C總共歷8小時,蒸餾出形成之乙酸。將混合物冷卻至 50— 60¾,然後用150毫升丙酮(或正-丁醇或乙酸乙酯)稀 釋,冷卻至0 — 5 °C,過滤及於真空及6 0 — 7 0 °C下乾燥,得 到148. 3克(4) (R= CH3),產率為90、。元累分析及光譜數 據證實推定之結構。 化合物_i(R = CH3) 1H HMR(DMSO-d<s. 2iC) H ^jpm) * 11.5 (1H, broad), 6 MS (m, broad; 80 Os), 8.13 (1H, s), 5.49 (2H, s), 4.09 (2H, m), 3.71 (2H·, m), (3H, s); 13C NMR(DMS0) δ (ppm) = 170.16, 1^2.79, 155.5, 148.97, Η7.26.Ί39.97, 120.4, 72.22, 66.84, 62.<S4,20.58; IR υ (cnrl)單 3】00· 2940. 2920, 2790, Γ740, I’m 1360, i500, J290; MS (e〇 rn/c: 295 〇6). 261 <l〇). 208 (9), 192 (12); i&i (] 'k)t {51 .(35), 87 (100)-, 元素分析(CuUsOs)%實驗值U诂計值):c = 44.86(4 4.75) (請先間讀背面之注意事項再IP本頁) 裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公潑) 9 修正買 A6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(2 ) - 化步驟,且對所欲産物之産率亦不利。 現驚異地發現用2-氧雜-1,4-二乙醯氧丁烷在N2-甲醯基 鳥嘌昤上烷化嘌昤環之9-位可以高産率得到阿塞克樓佛, 旦實質上可防止不欲的7 -異構物形成。N2 -甲醇基鳥嘌昤 被述於文獻(Shapiro, Biochemistry, 8, 231-245(1969)) 中。根據該作者,N2 -甲醯基鳥瞟昤可藉過碘酸鈉及/或 過碘酸處理乙二醛-鳥嘌昤加成物而得到;事實上,該法 之高産率具再現性,惟在本發明之方法中,N2 -甲酸基鳥 嘌昤亦可以其他方式得到,此等方式諸如: 一用過乙酸或過氧化氫或四乙酸鉛氧化乙二醛鳥嘌昤加 成物; —於存在或不存在溶劑諸如二甲基甲酿胺或二甲基亞® 下,且視情況可存在二環己基碩化二醯亞胺下,用甲酸直' 接甲鼯化鳥嘌昤; —用甲醯基乙酐直接甲醯化鳥嘌昤,視情況可在溶劑諸 如二甲基甲醯胺、二甲基亞颯、六甲基磷酸三醯胺或甲酸 存在下進行。 不論遵循何種步驟製備Η2 -甲醛基鳥嘌睑,該化合物接 下來與2 -氧雜-1 , 4 -二乙醯氧基丁烷之反應皆以9 0 %以上 之産率(更重要者,只形成微查的7-異構物),生成Ν2-甲 醛基-9-(2 -乙醯氣基)乙氧甲基鳥噤昤,後者最終不是在 單一步驟中用餘水溶液去醯基,就是先在酸介質中去甲醯 基,然後藉鹼水解去乙醛基。下列圖式摘要本發明之製程。 ......................ri:iiri:,:...........©:.i:^........................玎..........-ii-:4,..) {請先閱讀背面之注意事項再填窝本頁) 本紙張尺度適用令國國家標準(CNS)甲4規格(210x297公釐) λ 五、發明説明(3 ) KM2z/zhThe preparation of poison) is described, for example, in Belgian Patent No. 833,006. This method starts with guanine, and first trimethylsilylates at the 3-amino * 6- and 9-positions. The resulting silylated intermediate is then treated with 2-benzylacetoxyethoxymethyl chloride, and K is formed (after the protective group is removed at the N2 and He positions) 9- (2-fluorenyloxy) -ethoxymethylguanine Ascetic Loufo was recovered from it by ammonia hydrolysis in methanol. This method uses a large excess of alkylating agent, so there are obvious problems of cost and waste. Furthermore, it leads to the formation of quite impure products, and the amount of 7-substituted isomers is unacceptable in terms of pharmaceutical pupae. . British patent 1,567, δ71 discloses another method, in which the protection of the amine group at the 2-position is carried out by hydration; the patent discloses that Methyl, propyl, butyl, and benzyl are used as fluorenyl groups, among which The only example mentioned is the reaction of Ν 2, 9 -diethylfluorenylguanine with 2 -oxa-1, 4 -diethylfluorenyloxybutane to give Ν 2 -ethylfluorenyl-9-(2 -acetamidine (Oxy) ethoxymethylguanine, which is then hydrolyzed to give the final acecrofo, the yield of this reaction is only if the 7-isomer is not formed in significant amounts (up to 13%) Satisfactory, but it requires expensive pure paper sizes to apply Chinese National Standards (CNS) Α4 specifications (210 公 297 mm) Ordered by the Central Consumers Bureau of the Ministry of Economic Affairs Printed by the Consumer Cooperatives -3- Amendment page A7 B7 Amendments to supplement this year 丨丨 Month 1 > Said the jade, invention description (7 mixed with 107.4 g (0.502 mol) NaI〇4) printed by the employee's consumer cooperative of the Central Standards Bureau of the Ministry of Economic Affairs and maintained the temperature by the help of a water bath 3 υ , Flail monitors the p p value to make it approximately within the range of 1.8-2.2. The reaction is a mild, constant exothermic reaction, in It was completed in about 2 hours after the addition of the oxidant. After completion, the reaction mixture was cooled to 5 13 and then filtered, washed with water and dried. S 2 g of methyl amidinoguanine (3) (yield: 96%), 1 ^ 1 ^ Analysis shows purity> 98%. 4 c) H2 -Methylmethyl-9- (ethoxy) ethoxymethylguanine (4, R = CH3) 100 g (0.55 9 mol) of formazan Fluorinoguanine (3), 300 g (1.705 mol) of 2-oxo-1,4-diethylfluorenyl-butane and 2 g (0.0105 mol) of p-toluenesulfonic acid on an oil bath In a 500 ml round bottom flask equipped with a thermometer and a distillation device. Depressurize the system (30-40fflflllU) and heat the material to an internal temperature of 1 1 — 1 2 2 ° C in about 1 hour. The temperature was maintained at U S -1 2 2 C for a total of 8 hours, and the acetic acid formed was distilled off. The mixture is cooled to 50-60 ° C, then diluted with 150 ml of acetone (or n-butanol or ethyl acetate), cooled to 0-5 ° C, filtered and dried under vacuum at 60-70 ° C to obtain 148.3 g (4) (R = CH3), yield 90%. Elementary analysis and spectral data confirm the putative structure. Compound_i (R = CH3) 1H HMR (DMSO-d < s. 2iC) H ^ jpm) * 11.5 (1H, broad), 6 MS (m, broad; 80 Os), 8.13 (1H, s), 5.49 (2H, s), 4.09 (2H, m), 3.71 (2H ·, m), (3H, s); 13C NMR (DMS0) δ (ppm) = 170.16, 1 ^ 2.79, 155.5, 148.97, Η7.26 .Ί39.97, 120.4, 72.22, 66.84, 62. <S4,20.58; IR υ (cnrl) Single 3] 0 · 2940. 2920, 2790, Γ740, I'm 1360, i500, J290; MS (e〇 rn / c: 295 〇6). 261 < l〇). 208 (9), 192 (12); i & i (] 'k) t {51. (35), 87 (100)-, elemental analysis (CuUsOs)% experimental value U 诂 counted): c = 44.86 (4 4.75) (Please read the precautions on the back first, then the IP page) Installation · This paper size is applicable to China National Standard (CNS) A4 specifications (2 丨OX297 public splash) 9 amended to buy A6 B6 printed by the Consumers Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (2)-the transformation step, and it is not good for the yield of the desired product. It was surprisingly found that the alkylation of the 9-position of the purine ring on N2-formylguanosine with 2-oxo-1,4-diethyloxobutane gave Asek Loufo in high yield, Denier can substantially prevent unwanted 7-isomer formation. N2-Methanol-based guanine is described in the literature (Shapiro, Biochemistry, 8, 231-245 (1969)). According to the author, N2-formylguanosine can be obtained by treating glyoxal-guanine adducts with sodium periodate and / or periodate; in fact, the high yield of the method is reproducible However, in the method of the present invention, N2-formylguanine can also be obtained in other ways, such as:-oxidizing glyoxal guanine adduct with peracetic acid or hydrogen peroxide or lead tetraacetate; -In the presence or absence of a solvent such as dimethylformamide or dimethylimide, and optionally dicyclohexyl sulfonium diimine, directly formazanate guanine with formic acid; -Direct methylation of guanine with formamidine acetic anhydride, optionally in the presence of a solvent such as dimethylformamide, dimethylmethane, trimethylamine hexamethylphosphate or formic acid. No matter what steps are followed to prepare the hydrazone 2-formaldehyde guanine eyelid, the subsequent reaction of the compound with 2-oxo-1,4-diethoxybutane is in a yield of more than 90% (more importantly , Only the 7-isomer of microscopic examination is formed) to form N2-formyl-9- (2-ethylfluorenyl) ethoxymethylguanosine, which in the end is not a single step using the remaining aqueous solution to remove the fluorenyl group. That is, the methylidene group is first removed in an acid medium, and then the acetaldehyde group is removed by alkali hydrolysis. The following diagram summarizes the process of the present invention. ......... ri: iiri:,: ........... ©: .i: ^ ..... ......... 玎 .............- ii-: 4, ..) {Please read the notes on the back before filling the nest (This page) The paper size is applicable to the national standard (CNS) A4 specification (210x297 mm) λ 5. Description of the invention (3) KM2z / en

Hz >x 0 sHz > x 0 s

o A6 B6 · CHO Iho y 0o A6 B6 · CHO Iho y 0

π 画抖 (請先閲讀背面之注意事項再填寫本頁) .装. .訂· Φ 經濟部中央標準局印裝 oh o H s TsOH o / >}、π Shake (please read the precautions on the back before filling out this page).... Order. Φ Printed by the Central Bureau of Standards of the Ministry of Economic Affairs oh o H s TsOH o / >},

O .線* 經濟部中央標準局員工消費合作社印製 A 6 ___B6 五、發明説明(:t ) 在該圖式中,R為氬,Q-C4烷基或苯基。二元醇産物(2) 可藉將鳥嘌昤(1 )懸浮於水中,加入乙二醛水溶液及將混 合物加熱至8 0 υ歴4小時而以高産率回收(R . S h a p i r 〇 , 1o c. c i t ; R. Shapiro及 J. Haehraann , Biochemistry 5 , 2799(1966))。二元醇(2)然後在pH保持1.8 - 2.2之水中, 以化學計量之N a I 04氧化,而以極佳産率形成甲醯衍生物 (3) 〇 然後令N2-甲醯基鳥嘌昤(3 )(其如前述,亦可藉直接甲 酸化鳥曙昤而得到)行烷基化反應,可以高産率得到N - 9烷 基化化合物(4 ),而未形成明顯比率之N - 7烷基化産物;最 後用N a 0 Η水溶液水解化合物(4 )可以極佳産率得到阿塞克 樓彿(I)。 總言之,上述合成法允許所欲産物(I )以極令人滿意之 産率獲得,該産率高於經由乙醯鳥瞟昤合成法所得到者, 最重要者不會形成顯箸量之.7 -烷基化産物。 在另一具體例中,本發明之方法提供一最終純化步驟, 以得到實質不含鳥嘌昤之阿塞克樓彿。該純化步驟提供極 高純度之阿塞克樓佛。 己發現在強陰離子交換樹脂上溶離阿塞克樓彿之鹸性水 溶液,可以得到實質上不含鳥嘌昤之所欲産物。 根據本發明,純化步驟包含: a )將阿塞克樓佛溶入厳性水溶液中並用水稀釋如此得到 的溶液; b )將a )製得之稀溶液裝載於強陰離子交換柱上,樹脂與 (諳先閱讀背面之注意事項再填寫本頁) -裝 訂: -線- 本紙張尺度適用中國國家標準(CNS)甲4规格(210X297公釐) 6 經濟部中央標準局員工消費合作社印製 A6 B6 五、發明説明(5 ) 阿塞克樓彿之重量比為2 ·· 1 . 5 ; c) 以20Θ— 300毫升/小時之速率溶離該稀釋溶液; d) 用體積比為0.8: 1.2之低碩醇/鹼水溶液混合物組成 之溶離劑溶離阿塞克樓佛,溶離劑與阿塞克樓佛之v / w比 為1 5 : 1至2 0 : 1升/公斤且溶離速率與c)同,得到溶出物; e) 自d)之溶出物中單離出阿塞克樓彿。 陰離子交換樹脂為鹼型樹脂,其由具一些交聯度且擄帶 四级銨基之樹脂組成。本發明所用之樹脂為強鹸型樹脂。 強鹼樹脂之例有糊精、瓊脂、纖維素、二乙烯苯,彼等 以四级銨基適當官能化。 此等樹脂在市面上通常以Araberlite& , Dowex^ , Set>hacelR , SephadexR 等商標供應。 以 Amber 1 iteR IRA- 4 0 0 , Re 1 iteR 3A,IMAC ΗP - 441為 較佳。 層析在鹼型之樹脂之進行。 溶離於室溫下進行。 a)之鹼水溶液由鹸金屬氫氧化物(諸如氫氧化鋰、鈉或 鉀)溶液組成。鹼濃度為5 — 1 5 %,以1 0 %氫氣化鈉溶液為 較佳。 樹脂與阿塞克樓彿之w / w比以1 . 7 5為較佳。 較佳之溶離速率為2 5 0毫升/小時。 d )之低碳醇為甲醇、乙醇、丙醇。d)之鹼水溶液由濃度 為0.8至1.2M之鹼金屬氫氧化物組成。甲醇/1M氫氣化鈉 之V / V比以1 : 1為較佳。 ...........-........------------r!-,,:…:Ί:!Θ..............裝 ..............…:--tri-..............................€', (請先閱讀背面之注意事項再填窝本頁) 本紙張尺度適用中國國家標準(CNS)甲4規格(210x297公釐) q A6 B6 經濟部中央標準局員工消費合作社印製 五、發明説明(6 ) 溶離劑/ pg塞克樓彿之V / w fcb以1 7 . 5升/公斤為較佳。 在e)中自溶出物單離出産物傺根據習用技術進行。較好 用適當酸酸化溶出物而沈澱。 如此得到之産物之鳥嗦昤含量低於0 . 1 。 根據本發明之純化步驟,如此得到之阿塞克樓佛比市售 最佳産品純3至4倍。 - 上述純形式之阿塞克樓佛為本發明之另一目的。 本發明之純化步驟可應用於毎種其他已知之阿塞克樓佛 之製法。舉例言之,上述BE 833,006及GB 1,567,671之方 法得到之最終産物含有1至3 .¾鳥嘌昤,既然美國藥典規定 其最大上限為0 . 7 5¾,該量為不可接受之量。 所以,如上述阿塞克樓佛之純化構成本發明之另一目的。 下列實施例進一步說明本發明之製程。 實施例1 a )乙二柽鳥嘌昤(2 ) 將100克(0.662莫耳)鳥嘌昤,800毫升H2〇及150毫升40 % w / w乙二醛水溶液(1 . 3 2莫耳)於室溫下,在裝有冷凝器 、溫度計及磁攪棒之2升圖底燒瓶中混合,並將該混合物 加熱至80°C歴4小時,之後將燒瓶的内容物逐漸冷卻至5¾ ,然後過濾及用水洗滌,得到1 3 S克産物(産率:9 8 ?< ), HPLC分析顯示純度798 ?·^。 b ) N 2 -甲酸基鳥嘌昤(3 ) 在100克(0.478莫耳)乙二醛鳥嗦昤懸浮於800毫升水(用 6毫升Η 3 P 〇4將p Η值調至1 . 8至2 . 2 )之懸浮液中,於機械攪 (請先閱讀背面之注意事項再填窝本頁) 裝 訂. -象' 本紙張尺度適用中國國家標準(CNS) Τ 4規格(210 X 297公愛) 8 A7 B7 修正補充 本年丨丨月1>曰 經濟部中央標準局員工消費合作社印製 玉、發明説明(7 拌下加人107 .4克(0· 502奠耳)NaI〇4並藉水浴之助將溫度 保持3 0 υ,連纊監測p Η值,使其大致在1 . 8 - 2 . 2之範圍内 。反應為一種溫和、恆定的放熱反應,於加入氧化劑後約 2小時完成。完成後,將反應混合物冷卻至5 13,然後過濾 ,用水洗滌及乾燥。得到S 2克甲醯基鳥嘌呤(3 )(產率:9 6 %),1^1^分析顯示纯度>98%。 4 c)H2 -甲醯基-9-(乙醯氧基)乙氧甲基鳥嘌呤(4,R=CH3) 將100克(0.55 9莫耳)甲醯基鳥嘌呤(3),300克(1.705莫 ΐ)2-氧雜-1,4-二乙醯氧基-丁烷及2克(0.0105莫耳)對-甲苯磺酸置於油浴上,裝有溫度計及蒸餾裝置之5 0 0毫升 圓底燒瓶中。將該系統減壓( 30-40fflflllU)並將物質在約1小 時内加熱至内部溫度為1 1 S — 1 2 2 °C。將溫度保持在U S -1 2 2 C總共歷8小時,蒸餾出形成之乙酸。將混合物冷卻至 50— 60¾,然後用150毫升丙酮(或正-丁醇或乙酸乙酯)稀 釋,冷卻至0 — 5 °C,過滤及於真空及6 0 — 7 0 °C下乾燥,得 到148. 3克(4) (R= CH3),產率為90、。元累分析及光譜數 據證實推定之結構。 化合物_i(R = CH3) 1H HMR(DMSO-d<s. 2iC) H ^jpm) * 11.5 (1H, broad), 6 MS (m, broad; 80 Os), 8.13 (1H, s), 5.49 (2H, s), 4.09 (2H, m), 3.71 (2H·, m), (3H, s); 13C NMR(DMS0) δ (ppm) = 170.16, 1^2.79, 155.5, 148.97, Η7.26.Ί39.97, 120.4, 72.22, 66.84, 62.<S4,20.58; IR υ (cnrl)單 3】00· 2940. 2920, 2790, Γ740, I’m 1360, i500, J290; MS (e〇 rn/c: 295 〇6). 261 <l〇). 208 (9), 192 (12); i&i (] 'k)t {51 .(35), 87 (100)-, 元素分析(CuUsOs)%實驗值U诂計值):c = 44.86(4 4.75) (請先間讀背面之注意事項再IP本頁) 裝· 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨OX297公潑) 9 修正買 CS8C84 kl B7 五、發明説明(β ) ,H = 4.45(4.44),H = 22.25(23.72),0 = 28. 12(27.09). d )阿塞克樓佛(I) 將 65克(0.220莫耳)(4)(R = CH3)分散於 650毫升 5¾ NaOH 溶液中,檢査固體是否完全溶解。攪拌1 2小時後,將混合 物用H Cil水溶液中和至p Η為5 — 6。將流漿冷卻至2 0 — 2 5 °C ,將餅過濾及用4 0 0毫升去雛子水洗滌。於真空及6 0 — 7 0 °C下乾燥後*得到4 6 . 1克阿塞克樓佛(I ),產率9 3 % 。 實施例2 a)9-(2 -乙醢氧蕋)乙氧甲基鳥嘌呤(6) 將3 0 0毫升9 5 % E t 0 Η,2 9 . 5克(0 · 1莫耳)中間物(4 )及 40.4克(0.4莫耳)Et3f^於裝有溫度計、攪拌器及球型冷 凝劑之5 0 0毫升圓底燒瓶中。將物質回流5小時。將p Η值用 HC1水液調整至5— 6,然後將混合物冷卻至15— 20 °C,將 餅過濾及用2 0 0毫升去離子水洗滁。於真空及6 0 — 7 0 °C下 乾燥後,得到2 2 . 8克(6 )(產率:8 5 ‘;0。 b )阿塞克樓佛(I) 如實施例1 d )所述,將2 6 . 7克(0 . 1莫耳)(6 )用5 % N a 0 Η 處理。阿塞克樓佛Κ 9 4 %之產率得到,大致接近理論值。 實施例3 ' 遵循貿施例1之步驟,但不用2 -氧雜-1,4 -二乙醯氧基丁 烷,而用對應量之2-氧雜-1 , 二甲醯氧基丁烷或2-氧雜- 1 , 4 -二苄醯氧基丁烷行N 2 -甲醯基鳥嘌呤之烷化。Μ大致 與實施例1 c )相同之產率分別得到其中R == Η或R =苯基之 中間物(4 ),根據實施例1 d)自該中間物很易得到阿塞克 本紙張尺度適用中國國家標準(CNS ) A4规格(2)0X297公釐) -10-~修正頁~ ----------裝-- (#先聞讀背面之注意事項本頁) 、-'° 線 經濟部中央標準局員工消費合作社印製 A7 B7 386084 五、發明説明(9 ) 樓佛;其中從(4)(R =苯基)起始,可以得到阿塞克樓佛, 產率為90¾。 化合物生(R =苯基) ΪΗ NMR(DMS〇A. 25 0) 6 (pppi) = U.5 (Hi broad), 8,S7 (UI, Uoaxi; 80 C=s), 8.20 (1H, 4 8.15-7.50 (5H, m), 5.51 (2H; c). 4Λ6 (2U, mX;3.77 (2Iit ra); MS (ci) m/c: 357 (M l-, 28), 236 (35), 151 (37). &7 〇00); 元素分析(C : i H t 3 N 5 0 5 ) 實驗值(S:估計值):C = 5 4 . 0 1 ( 5 3 . 7 8 ) ,H = 4‘21(4.20) ,N = 22.44(22.41),0 = 19‘56 (19.6 1). 實施例4 將δ 7 . 5克(1 2 5毫升,視密度=0 . 7 )強鹼性樹脂( AMBERLITE IRA-400 )懸浮於去離子水中,然後將其裝入層O. Line * Printed by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs A 6 ___B6 V. Description of the Invention (: t) In the figure, R is argon, Q-C4 alkyl or phenyl. The glycol product (2) can be recovered in high yield by suspending guanine (1) in water, adding an aqueous solution of glyoxal, and heating the mixture to 80 ° F for 4 hours (R. S hapir 〇, 1o c. cit; R. Shapiro and J. Haehraann, Biochemistry 5, 2799 (1966)). The diol (2) is then oxidized with stoichiometric N a I 04 in water maintained at a pH of 1.8-2.2 to form a formamidine derivative (3) in an excellent yield, and then N2-formamylguanine昤 (3) (which can also be obtained by directly formicating the bird's pupa as above) can be alkylated to obtain N-9 alkylated compound (4) in high yield without forming a significant ratio of N. -7 alkylation product; finally, hydrolyzing compound (4) with an aqueous solution of Na 0 得到 to obtain Aseklaufo (I) in excellent yield. In summary, the above synthesis method allows the desired product (I) to be obtained in a highly satisfactory yield, which is higher than that obtained by the acetonitrile synthesis method, and the most important one does not form a significant amount No. 7-alkylation products. In another specific example, the method of the present invention provides a final purification step to obtain Asseq Lou Buddha which is substantially free of guanine. This purification step provides very high purity Assyk Loufo. It has been found that by dissolving the alkaline aqueous solution of Aseklaufo on a strong anion exchange resin, a desired product substantially free of guanine can be obtained. According to the present invention, the purification step comprises: a) dissolving the Assyrian Loufo in an alkaline aqueous solution and diluting the solution so obtained with water; b) loading the dilute solution prepared by a) on a strong anion exchange column, the resin and (谙 Please read the notes on the back before filling this page)-Binding:-Thread-This paper size is applicable to China National Standard (CNS) A4 specifications (210X297 mm) 6 Printed by A6 B6, Consumer Cooperative of Central Standards Bureau, Ministry of Economic Affairs V. Description of the invention (5) The weight ratio of Aseklou Buddha is 2. · 1.5; c) The diluted solution is dissolved at a rate of 20Θ-300ml / hour; d) The volume ratio is as low as 0.8: 1.2 The dissolving agent composed of the master alcohol / alkaline aqueous solution dissolves the azeklofo, and the v / w ratio of the leaching agent and the acelofo is 15: 1 to 20: 1 liter / kg, and the dissolution rate is the same as c) To obtain the dissolve; e) separate the Assyrian Buddha from the dissolve in d). The anion exchange resin is a basic resin, which is composed of a resin having some degree of crosslinking and having a quaternary ammonium group. The resin used in the present invention is a strong concrete resin. Examples of strong base resins are dextrin, agar, cellulose, divinylbenzene, which are appropriately functionalized with a quaternary ammonium group. These resins are usually supplied on the market under the trademarks Araberlite &, Dowex ^, Set & hacelR, SephadexR and the like. Amber 1 iteR IRA- 4 0 0, Re 1 iteR 3A, IMAC ΗP-441 is preferred. Chromatography was performed on a basic resin. Dissolution was performed at room temperature. The alkaline aqueous solution of a) consists of a solution of a rhenium metal hydroxide such as lithium hydroxide, sodium or potassium hydroxide. The alkali concentration is 5 to 15%, and a 10% sodium hydroxide solution is preferred. The w / w ratio of the resin to the Assyrian Buddha is preferably 1.75. The preferred dissolution rate is 250 ml / h. d) The lower alcohols are methanol, ethanol, and propanol. d) The aqueous alkali solution is composed of an alkali metal hydroxide having a concentration of 0.8 to 1.2M. The V / V ratio of methanol / 1M sodium hydride is preferably 1: 1. ...........-........------------ r!-,,: ...: Ί:! Θ ...... ............. Installed ....................: --tri -.............. ......... € ', (Please read the notes on the back before filling in this page) This paper size applies to China National Standard (CNS) A4 specification (210x297 mm) q A6 B6 Central Ministry of Economic Affairs Printed by the Consumer Bureau of the Standards Bureau. V. Description of the invention (6) The dissolving agent / pg of the Seco Loufo V / w fcb is preferably 17.5 liters / kg. The eluate is isolated from the product in e), according to conventional techniques. The leachate is preferably acidified with a suitable acid and precipitated. The bird's wren content of the product thus obtained was less than 0.1. According to the purification step of the present invention, the best product commercially available in Asseq Loufoby thus obtained is 3 to 4 times pure. -The above-mentioned pure form of the Assyrian Buddha is another object of the present invention. The purification step of the present invention can be applied to a variety of other known methods of making Aseki Lou Buddha. For example, the final product obtained by the above methods of BE 833,006 and GB 1,567,671 contains 1 to 3.¾guanine. Since the maximum limit of the US Pharmacopeia is 0.75 ¾, this amount is an unacceptable amount. Therefore, the purification of the Assyrian Lou Buddha constitutes another object of the present invention. The following examples further illustrate the process of the present invention. Example 1 a) Ethylenediguanosine (2) 100 g (0.662 moles) of guanine, 800 ml of H2O and 150 ml of a 40% w / w glyoxal aqueous solution (1.3 2 moles) At room temperature, mix in a 2-liter figure bottom flask equipped with a condenser, thermometer, and magnetic stir bar, and heat the mixture to 80 ° C for 4 hours. After that, gradually cool the contents of the flask to 5¾, then Filtration and washing with water gave 1 3 S of the product (yield: 9 8? ≪). HPLC analysis showed a purity of 798? b) N 2 -formylguanosine (3) suspended in 100 g (0.478 moles) of glyoxal guanosine in 800 ml of water (using 6 ml of Η 3 P 〇 4 to adjust the p Η value to 1.8 To 2.2) in the suspension, mechanical binding (please read the precautions on the back before filling this page) binding.-Elephant 'This paper size is applicable to China National Standard (CNS) T 4 specifications (210 X 297) Love) 8 A7 B7 amended and supplemented this year 丨 丨 January 1> said the jade and invention description printed by the staff consumer cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (7 mixed with 107.4 g (0.502 Mear) NaI〇4 and With the help of a water bath, the temperature is maintained at 30 υ, and the p Η value is monitored to make it approximately within the range of 1.8-2.2. The reaction is a mild, constant exothermic reaction, about 2 hours after the oxidant is added Completed. After completion, the reaction mixture was cooled to 5 13 and then filtered, washed with water and dried. S 2 g of methyl amidinoguanine (3) was obtained (yield: 96%), 1 ^ 1 ^ analysis showed purity > 98%. 4 c) H2-formyl-9- (ethoxy) ethoxymethylguanine (4, R = CH3) 100 g (0.55 9 moles) formylguanine (3 ), 300 grams (1.705 moles) 2-oxo-1,4-diethoxyl-butane and 2 grams (0.0105 moles) of p-toluenesulfonic acid are placed on an oil bath, equipped with a thermometer and a distillation apparatus. 0 ml round bottom flask. Depressurize the system (30-40fflflllU) and heat the material to an internal temperature of 1 1 — 1 2 2 ° C in about 1 hour. The temperature was maintained at U S -1 2 2 C for a total of 8 hours, and the acetic acid formed was distilled off. The mixture is cooled to 50-60 ° C, then diluted with 150 ml of acetone (or n-butanol or ethyl acetate), cooled to 0-5 ° C, filtered and dried under vacuum at 60-70 ° C to obtain 148.3 g (4) (R = CH3), yield 90%. Elementary analysis and spectral data confirm the putative structure. Compound_i (R = CH3) 1H HMR (DMSO-d < s. 2iC) H ^ jpm) * 11.5 (1H, broad), 6 MS (m, broad; 80 Os), 8.13 (1H, s), 5.49 (2H, s), 4.09 (2H, m), 3.71 (2H ·, m), (3H, s); 13C NMR (DMS0) δ (ppm) = 170.16, 1 ^ 2.79, 155.5, 148.97, Η7.26 .Ί39.97, 120.4, 72.22, 66.84, 62. <S4,20.58; IR υ (cnrl) Single 3] 0 · 2940. 2920, 2790, Γ740, I'm 1360, i500, J290; MS (e〇 rn / c: 295 〇6). 261 < l〇). 208 (9), 192 (12); i & i (] 'k) t {51. (35), 87 (100)-, elemental analysis (CuUsOs)% experimental value U 诂 counted): c = 44.86 (4 4.75) (Please read the precautions on the back first, then the IP page) Installation · This paper size is applicable to China National Standard (CNS) A4 specifications (2 丨OX297 public splash) 9 amendments to buy CS8C84 kl B7 V. Description of the invention (β), H = 4.45 (4.44), H = 22.25 (23.72), 0 = 28. 12 (27.09). D) Asek Loufo (I ) Disperse 65 g (0.220 mol) (4) (R = CH3) in 650 ml of 5¾ NaOH solution and check if the solid is completely dissolved. After stirring for 12 hours, the mixture was neutralized with an aqueous solution of H Cil to a pH of 5-6. The slurry is cooled to 20-25 ° C, the cake is filtered and washed with 400 ml of deionized water. After drying under vacuum at 60-70 ° C *, 46.1 g of Assekloufo (I) was obtained with a yield of 93%. Example 2 a) 9- (2-Ethoxypyridine) ethoxymethylguanine (6) 300 ml of 95% E t 0 Η, 29.5 g (0.1 mole) (4) and 40.4 g (0.4 mol) of Et3f ^ in a 500 ml round-bottomed flask equipped with a thermometer, a stirrer and a spherical condensing agent. The material was refluxed for 5 hours. Adjust the pΗ value to 5-6 with HC1 water, then cool the mixture to 15-20 ° C, filter the cake and wash with 200 ml of deionized water. After drying under vacuum at 60-70 ° C, 22.8 g (6) was obtained (yield: 85 '; 0. b) Asekloufo (I) as in Example 1 d) As described, 26.7 g (0.1 mol) (6) was treated with 5% Na 0Η. Yield of 94% was obtained for Assek Loufo, which is approximately close to the theoretical value. Example 3 'The procedure of Example 1 was followed, but instead of 2-oxo-1,4-diethoxybutane, a corresponding amount of 2-oxo-1, dimethylphenoxybutane was used. Or 2-oxo-1,4-dibenzylacetoxybutane is alkylated with N 2 -formylguanosine. Μ was obtained in the same yield as in Example 1 c). The intermediate (4) in which R == Η or R = phenyl was obtained, respectively. According to Example 1 d), the Asperk paper size was easily obtained from the intermediate. Applicable to China National Standard (CNS) A4 specification (2) 0X297 mm) -10- ~ correction page ~ ---------- install-(#xianwen read the precautions on the back page),- '° Line printed by the Consumer Cooperatives of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 386084 V. Description of the invention (9) Lou Buddha; where starting from (4) (R = phenyl), Asek Lou Buddha can be obtained. Yield It is 90¾. Compound (R = phenyl) ΪΗ NMR (DMS〇A. 25 0) 6 (pppi) = U.5 (Hi broad), 8, S7 (UI, Uoaxi; 80 C = s), 8.20 (1H, 4 8.15-7.50 (5H, m), 5.51 (2H; c). 4Λ6 (2U, mX; 3.77 (2Iit ra); MS (ci) m / c: 357 (M l-, 28), 236 (35), 151 (37). &Amp; 7 00); elemental analysis (C: i H t 3 N 5 0 5) experimental value (S: estimated value): C = 5 4. 0 1 (5 3. 7 8), H = 4'21 (4.20), N = 22.44 (22.41), 0 = 19'56 (19.6 1). Example 4 δ 7.5 g (125 ml, apparent density = 0.7) strong base Resin (AMBERLITE IRA-400) is suspended in deionized water, and then it is loaded into the layer

析柱(直徑='4cm,= 40cm)中.。進行一般的再生處理(用2M H a 0 Η,2 Μ H C il ,2 Μ N a 0 Η及去離子水接續溶離,直至中性) 後,將50克阿塞克樓佛溶於100毫升10¾ HaOH溶液並用水稀 釋至200毫升所得之溶液装入柱中,然後M250毫升/小時 (4 . 2毫升/分鐘)之流速溶離該溶液。溶離上述溶液後, 將該柱Μ相同流速用900毫升1 : lv/v MeOH/lM NaOH混合 物溶離。將如此得到之溶出物用丨丨C 1水液調整至p Η為5 - 6 。將析出之固體過濾,用水洗滌及乾燥。得到4 5克不含鳥 嘌呤之阿塞克樓佛(產率:9 0 % )。 實施例5 從鳥嘌呤及甲酸製備甲醢基鳥嘌呤 ^ 將鳥嘌呤(20克,0. 13莫耳)和9δίϋ甲酸(2 00毫升)之混合 物進行回流達4 8小時,然後降溫到0〜5 °C,並加Μ過濾。 所得固形物Κ水(1 0 0毫升X 2 )加Κ沖洗*並在4 ο υ *抽真 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) -11,—修正貫 ----------裝-- (請先聞讀背面之注意事項再$本頁) 訂 -線 經濟部中央標準局員工消費合作社印製 386084 A7 B7 五、發明説明(10) 空下,乾燥而得甲醯基鳥嘌呤(3 )(1 1克,Η P L C婢度9 8 %, 0.06莫耳*產率46¾) 實施例6 從鳥嘌呤及甲藤基乙酐製備甲醯基鳥嘌呤 將鳥嘌呤(1 0 0克,0. 6 6莫耳)和剛蒸餾過的甲k基乙酐( 2 7 0毫升)之混合物,在40 °C,通氮氣下放置12小時,然後 再在8 0它下多放置1 2小時,該混合物冷卻至室溫,然後過 濾,所得固形物> Κ甲醇(1 0 0毫升X 2)加以沖洗。該固形 物接著在40¾ *抽真空下,乾燥而得甲醯基鳥嘌呤(3)(91 克,HPLC純度97%,0.49莫耳,產率75¾) ----------^------II----.——— 0 (請先閲讀背面之注意事項再頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)Analytical column (diameter = '4cm, = 40cm). After performing general regeneration treatment (using 2M H a 0 Η, 2 MH HC il, 2 MH N a 0 Η and deionized water to dissolve until neutrality), 50 g of Assekloufo was dissolved in 100 ml of 10¾ The solution of HaOH was diluted with water to 200 ml, and the resulting solution was packed into a column, and then the solution was dissolved at a flow rate of M 250 ml / hour (4.2 ml / minute). After dissolving the above solution, the column was dissolved with 900 ml of a 1: lv / v MeOH / 1M NaOH mixture at the same flow rate. The leachate thus obtained was adjusted to p Η with C 1 aqueous solution to 5-6. The precipitated solid was filtered, washed with water and dried. 45 g of acerine-free Buddha was obtained (yield: 90%). Example 5 Preparation of formamylguanine from guanine and formic acid ^ A mixture of guanine (20 g, 0.13 mol) and 9δ fluorene formic acid (200 ml) was refluxed for 48 hours, and then cooled to 0 ~ 5 ° C and filtered with Μ. The resulting solids K water (100 ml X 2) plus K rinse * and draw the paper size at 4 ο υ * the true size of the paper applies the Chinese National Standard (CNS) A4 specification (210 × 297 mm) -11, -corrected consistently- -------- Equipment-(Please read the precautions on the back first and then $ this page) Order-Printed by the Central Consumers Bureau of the Ministry of Economic Affairs, Consumer Cooperatives 386084 A7 B7 V. Description of Invention (10) , And dried to give methyronine guanine (3) (11 g, Η PLC degree 98%, 0.06 mole * yield 46¾) Example 6 Preparation of methyronine from guanine and methenyl acetic anhydride Mix a mixture of guanine (100 g, 0.66 mol) and freshly distilled methyl acetic anhydride (270 ml) at 40 ° C under nitrogen for 12 hours, and then place in It was left under it for an additional 12 hours, the mixture was cooled to room temperature, and then filtered, and the resulting solid was washed with K methanol (100 ml X 2). The solid was then dried under 40¾ * vacuum to obtain formamylguanine (3) (91 g, HPLC purity 97%, 0.49 mole, yield 75¾) ---------- ^ ------ II ----.------ 0 (Please read the notes on the back first and then the page) Printed on the paper by the Consumer Cooperatives of the Central Standards Bureau of the Ministry of Economic Affairs. 210X297 mm)

Claims (1)

386084 Α8 Β8 C8 D8 口386084 Α8 Β8 C8 D8 port 申請專利範圍 1.—種製備9-(2-羥基)乙氧甲基鳥嘌呤(阿塞克樓佛 acyclovir) (1)之方法: 〇Scope of patent application 1. A method for preparing 9- (2-hydroxy) ethoxymethylguanine (acyclovir) (1): 〇 含有Μ下步驟: (a)將鳥嘌呤與甲酸於溫度0〜5 °C下反應或與甲醢基乙 酐於溫度40〜8〇υ下反應,K形成式(3)之N2 -甲醯基鳥 嘌呤: Η,Steps containing M: (a) Reaction of guanine with formic acid at a temperature of 0 to 5 ° C or reaction with formamyl acetic anhydride at a temperature of 40 to 80 ° K, and K forms N 2 -formamidine of formula (3) Guanine: Η, (3) (請先閲讀背面之注意事項再填寫本頁) -----「裝------訂--- 經濟部中央梯隼局員工消費合作社印製 (b)將式(3)之Η2 -甲醯基鳥嘌呤與下式之2-氧雜-1,4-二醯氧基丁烷在對-甲苯磺酸存在下,於壓力為20-50inmHg 及溫度為11 0 - 1 3 0 °C下反應: 0 人 R 0 0 (其中R為氫、Ci〜C4烷基或苯基), Μ形成式(4)之N2-甲醯基-9- (2-醢氧基)乙氧甲基鳥 .—3^--- • -i - I - I In -B-1— - - I i I . I— I I 1^1 _1一 本紙張尺度適用中國國家標準(CNS ) A4規格(2iOX297公釐) 386084 Α8 Β8 C8 D8 口(3) (Please read the precautions on the back before filling out this page) ----- "Installation ------ Order --- Printed by the Staff Consumer Cooperative of the Central Echelon Bureau of the Ministry of Economic Affairs (b) 3) Η2-Methylmethylguanine and 2-oxo-1,4-dioxobutane of the following formula in the presence of p-toluenesulfonic acid at a pressure of 20-50 inmHg and a temperature of 11 0- Reaction at 1 3 0 ° C: 0 human R 0 0 (where R is hydrogen, Ci ~ C4 alkyl or phenyl), and M forms N2-methylfluorenyl-9- (2-fluorenyloxy) of formula (4) ) Ethoxymethyl bird. —3 ^ --- • -i-I-I In -B-1—--I i I. I— II 1 ^ 1 _1A paper size applies to the Chinese National Standard (CNS) A4 specification (2iOX297 mm) 386084 Α8 Β8 C8 D8 port 申請專利範圍 1.—種製備9-(2-羥基)乙氧甲基鳥嘌呤(阿塞克樓佛 acyclovir) (1)之方法: 〇Scope of patent application 1. A method for preparing 9- (2-hydroxy) ethoxymethylguanine (acyclovir) (1): 〇 含有Μ下步驟: (a)將鳥嘌呤與甲酸於溫度0〜5 °C下反應或與甲醢基乙 酐於溫度40〜8〇υ下反應,K形成式(3)之N2 -甲醯基鳥 嘌呤: Η,Steps containing M: (a) Reaction of guanine with formic acid at a temperature of 0 to 5 ° C or reaction with formamyl acetic anhydride at a temperature of 40 to 80 ° K, and K forms N 2 -formamidine of formula (3) Guanine: Η, (3) (請先閲讀背面之注意事項再填寫本頁) -----「裝------訂--- 經濟部中央梯隼局員工消費合作社印製 (b)將式(3)之Η2 -甲醯基鳥嘌呤與下式之2-氧雜-1,4-二醯氧基丁烷在對-甲苯磺酸存在下,於壓力為20-50inmHg 及溫度為11 0 - 1 3 0 °C下反應: 0 人 R 0 0 (其中R為氫、Ci〜C4烷基或苯基), Μ形成式(4)之N2-甲醯基-9- (2-醢氧基)乙氧甲基鳥 .—3^--- • -i - I - I In -B-1— - - I i I . I— I I 1^1 _1一 本紙張尺度適用中國國家標準(CNS ) A4規格(2iOX297公釐) AS B8 C8 D8 Ο(3) (Please read the precautions on the back before filling out this page) ----- "Installation ------ Order --- Printed by the Staff Consumer Cooperative of the Central Echelon Bureau of the Ministry of Economic Affairs (b) 3) Η2-Methylmethylguanine and 2-oxo-1,4-dioxobutane of the following formula in the presence of p-toluenesulfonic acid at a pressure of 20-50 inmHg and a temperature of 11 0- Reaction at 1 3 0 ° C: 0 human R 0 0 (where R is hydrogen, Ci ~ C4 alkyl or phenyl), and M forms N2-methylfluorenyl-9- (2-fluorenyloxy) of formula (4) ) Ethoxymethyl bird. —3 ^ --- • -i-I-I In -B-1—--I i I. I— II 1 ^ 1 _1A paper size applies to the Chinese National Standard (CNS) A4 specification (2iOX297 mm) AS B8 C8 D8 Ο (4) 386084 t、申請專利範圍 嘌呤:(4) 386084 t. Scope of patent application Purine: (其中R如上所定義); (c)將式(4)之N2 -甲醸基-9-(2-藤氧基)乙氧甲基鳥 嚷呤用稀氫氧化鈉水溶液處理1同時進行去-甲醯基化及 0-去醯基化,或是先在乙醇中用三乙胺處理Μ進行去-甲 醢基化,接著用稀氫氧化鈉水溶液處理Κ進行0-去醯基化 ,藉Κ得到式(I)之阿塞克樓佛。 (讀先聞讀背面之注意事項再填寫本頁) 經濟部中夬標準局員工消費合作社印製 —2 — 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐)(Wherein R is as defined above); (c) treating N2-methylamidin-9- (2-pentyloxy) ethoxymethylguanine of formula (4) with a dilute aqueous solution of sodium hydroxide at the same time; -Formamylation and 0-demethylation, or firstly treat M with triethylamine in ethanol for de-methylation, and then treat K with a dilute sodium hydroxide solution for 0-demethylation, Borrow KK to get the Assik Lou Buddha of formula (I). (Please read the notes on the reverse side and fill in this page) Printed by the Consumers' Cooperatives of the China Standards Bureau of the Ministry of Economic Affairs — 2 — This paper size applies to China National Standard (CNS) Α4 size (210 X 297 mm)
TW83102060A 1994-03-09 1994-03-09 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine TW386084B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW83102060A TW386084B (en) 1994-03-09 1994-03-09 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW83102060A TW386084B (en) 1994-03-09 1994-03-09 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine

Publications (1)

Publication Number Publication Date
TW386084B true TW386084B (en) 2000-04-01

Family

ID=21624635

Family Applications (1)

Application Number Title Priority Date Filing Date
TW83102060A TW386084B (en) 1994-03-09 1994-03-09 A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine

Country Status (1)

Country Link
TW (1) TW386084B (en)

Similar Documents

Publication Publication Date Title
US20070100149A1 (en) Process for preparing letrozole
TW311138B (en)
TW386084B (en) A process for the preparation of 9-(2-hydroxy)-ethoxymethyl-guanine
HU216330B (en) Process for producing and purificating iopamidol
TW315369B (en)
JPH09502707A (en) Method for producing 9- (2-hydroxy) ethoxymethylguanine
JP2618578B2 (en) Medicine
JPS60226879A (en) Manufacture of n1-methyl-10 alpha-methoxylumilysergol
JPH08333364A (en) D4 t polymorphism form i methods
JP2502327B2 (en) Method for producing diphenyl ether compound
US6861525B2 (en) Process for the preparation imidazo[1,2-A]pyridine-3-acetamides
CN113651762B (en) Preparation method of 1-methyl-1H-1, 2, 4-triazole-3-methyl formate
JP3059007B2 (en) Method for producing 1- (2-carboxyphenyl) indazole derivative
EP0773220B1 (en) 2-Amino-6-chloropurine and method for preparing the same
JP3105367B2 (en) Method for producing 4- (1-imidazolylmethyl) cinnamic acid
JP3246855B2 (en) Method for producing tetraammineplatinum (II) dichloride
JPS6337104B2 (en)
TW418202B (en) Preparation Process for Beno [5,6] Cycloheptapyridine Derivative
JP2942380B2 (en) Method for purifying methacrylamide
JPH1129572A (en) Purification of nucleic acid derivative
JPS59116251A (en) Preparation of tetramethylammonium salt
JPH10512895A (en) Purification method
JPS5832867A (en) Novel arylazopyrimidine compound
NL8300536A (en) OPTICALLY ACTIVE ALFA-AZIDO-P-HYDROXYPHENYLACACIC ACID AND ITS SALTS AND ITS PREPARATION.
JPS6337105B2 (en)